Alicia Olivo

Alicia Olivo

Executive Vice President, General Counsel and Business DevelopmentatNeogenomics· In proxies 2022–2025

Pay in FY2025+36% from the year before · Neogenomics stock -28.6% the same year

Alicia Olivo was paid $3.0M in FY2025 (Dec), up 36%. Neogenomics stock fell 28.6% that year.

Pay$100 in the stock at the end of FY21 → $34
Pay is from the Summary Compensation Table of each Neogenomics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NeogenomicsPublic company · 4 yr
    • Executive Vice President, General Counsel and Business Development2022 – Present · 4 yrStock in role -46%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?